Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

515
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
515
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

377
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
377
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

408
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
408
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.4K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Usage of a Paclitaxel-Coated Balloon With Urea Compared With Other Contemporary Drug-Coated Balloons: A 2-Year Analysis From SCAAR in Over 6000 Patients.

Journal of the American Heart Association·2026
Same author

Outcomes of No-Touch Vs Conventionally Harvested Saphenous Veins for Coronary Artery Bypass Surgery: Individual Patient Data Meta-Analysis Protocol.

CJC open·2026
Same author

Stroke after transcatheter aortic valve implantation: incidence, temporal trends and predictors.

Heart (British Cardiac Society)·2026
Same author

A deep learning ECG model for identification and localization of occlusion myocardial infarction.

Nature communications·2026
Same author

Abbreviated DAPT after PCI with drug coated balloons in acute coronary syndromes - insights from the SWEDEHEART registry.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Extending inferences from a randomized trial to trial-eligible and treatment-candidate target populations: examples of generalizability and transportability.

Epidemiology (Cambridge, Mass.)·2026

Related Experiment Video

Updated: Mar 19, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K

Bioresorbable Stents in PCI.

Daniel Lindholm1,2, Stefan James3,4

  • 1Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden. daniel.lindholm@ucr.uu.se.

Current Cardiology Reports
|June 18, 2016
PubMed
Summary
This summary is machine-generated.

Bioresorbable stents aim to avoid long-term complications of coronary stents but have not yet proven superior to drug-eluting stents, with some studies indicating increased stent thrombosis. Further research is needed for their clinical use.

Keywords:
Bioresorbable stentsCoronary artery diseasePercutaneous coronary intervention

More Related Videos

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

7.3K
Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
05:04

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access

Published on: November 19, 2020

5.0K

Related Experiment Videos

Last Updated: Mar 19, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.5K
Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
06:39

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

7.3K
Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access
05:04

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access

Published on: November 19, 2020

5.0K

Area of Science:

  • Cardiovascular medicine
  • Interventional cardiology
  • Biomaterials science

Background:

  • Percutaneous coronary intervention (PCI) has evolved significantly with the introduction of coronary stents to manage vessel recoil and complications.
  • Drug-eluting stents (DES) were developed to reduce neointimal hyperplasia and restenosis seen with bare metal stents.
  • Long-term issues with permanent metallic stents include potential inflammation, impaired vascular function, and very late stent thrombosis.

Purpose of the Study:

  • To review the current status of bioresorbable stents in percutaneous coronary intervention (PCI).
  • To evaluate the clinical outcomes and challenges associated with leading bioresorbable stent platforms.
  • To discuss the potential benefits and limitations of bioresorbable stent technology.

Main Methods:

  • Review of current literature on bioresorbable stents in PCI.
  • Focus on extensively studied platforms: ABSORB, DESolve, and DREAMS.
  • Analysis of clinical outcomes data comparing bioresorbable stents with current generation drug-eluting stents.

Main Results:

  • Bioresorbable stents have not demonstrated superiority over current drug-eluting stents in clinical outcomes.
  • A signal of increased stent thrombosis has been observed with bioresorbable stent use.
  • The long-term safety and efficacy profile requires further investigation.

Conclusions:

  • Bioresorbable stents offer theoretical advantages by degrading over time, potentially avoiding long-term complications.
  • Current clinical evidence does not support their routine use over established drug-eluting stents.
  • Further technological development and extensive long-term studies are essential before widespread clinical adoption.